LEADIANT BIOSCIENCES LIMITED
Get an alert when LEADIANT BIOSCIENCES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-04-29 (in 11mo)
Last made up 2026-04-15
Watchouts
None on the register
Cash
£2M
+190.1% vs 2023
Net assets
£42M
+94.4% vs 2023
Employees
8
-11.1% vs 2023
Profit before tax
£27M
+115.7% vs 2023
Name history
Renamed 1 time since incorporation
- LEADIANT BIOSCIENCES LIMITED 2016-12-05 → present
- SIGMA-TAU RARE DISEASE LIMITED 2015-04-15 → 2016-12-05
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £35,280,989 | £37,122,841 | |
| Operating profit | £21,510,062 | £25,396,854 | |
| Profit before tax | £12,535,439 | £27,034,773 | |
| Net profit | £10,073,847 | £20,255,068 | |
| Cash | £637,957 | £1,850,947 | |
| Total assets less current liabilities | £44,655,191 | £64,987,566 | |
| Net assets | £21,466,911 | £41,721,978 | |
| Equity | £21,466,911 | £41,721,978 | |
| Average employees | 9 | 8 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 61.0% | 68.4% | |
| Net margin | 28.6% | 54.6% | |
| Return on capital employed | 48.2% | 39.1% | |
| Gearing (liabilities / total assets) | 54.2% | 39.9% | |
| Current ratio | 18.13x | 15.19x | |
| Interest cover | 392.04x | 664.53x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Belluzzo Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements are prepared on a going concern basis which has been supported by the provision of a parental letter of support from its ultimate parent, Essetifin S.p.A. The letter of support confirms that the parent company will continue to support the Company for the period to 30 June 2028.”
Group structure
- LEADIANT BIOSCIENCES LIMITED · parent
- Leadiant Biosciences Ltd 1%
- Leadiant GmbH 1%
- Leadiant Biosciences Inc 1%
- Leadiant Biosciences Ireland Ltd 1%
Significant events
- “In November 2022, the Spanish competition authority (CNMC) initiated proceedings pursuant to Article 102 TFEU and imposed a fine of €10,250,000 for anti-competitive behaviour.”
- “In May 2022, the AGCM imposed a fine of €3,501,020 on Leadiant Biosciences Ltd for abuse of a dominant position.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SISEC LIMITED | Corporate Secretary | 2015-04-15 | — | — |
| ANDREIANU, Dan-Paul | Director | 2026-02-01 | Mar 1981 | British |
| BRUGHERA, Marco Maria | Director | 2015-04-15 | May 1955 | Italian |
| LAURETI, Lorenza | Director | 2022-04-01 | Dec 1965 | Italian |
| TONCHEVA, Daniella | Director | 2025-07-25 | Mar 1976 | Bulgarian |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BALL, Simon Miles | Director | 2022-04-01 | 2025-07-25 |
| BALL, Simon Miles | Director | 2017-03-06 | 2018-07-13 |
| CODONESU, Giuseppe | Director | 2015-04-15 | 2015-07-31 |
| DEVEQUE, Pierre Roger | Director | 2016-02-29 | 2018-07-13 |
| FORD, Michael | Director | 2015-04-15 | 2022-01-31 |
| MAIA DEVESA GAMA DA SILVA, Antonio Manuel | Director | 2015-04-15 | 2026-01-18 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 57 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-02-04 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-19 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-04 | AA | accounts | Accounts with accounts type full | |
| 2025-07-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-30 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-18 | CH01 | officers | Change person director company with change date | |
| 2024-10-12 | AA | accounts | Accounts with accounts type full | |
| 2024-07-16 | CH01 | officers | Change person director company with change date | |
| 2024-04-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-26 | AA | accounts | Accounts with accounts type full | |
| 2023-04-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-28 | AA | accounts | Accounts with accounts type full | |
| 2022-04-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-04-13 | AP01 | officers | Appoint person director company with name date | |
| 2022-04-12 | AP01 | officers | Appoint person director company with name date | |
| 2022-02-14 | TM01 | officers | Termination director company with name termination date | |
| 2021-07-07 | AA | accounts | Accounts with accounts type full | |
| 2021-04-19 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+5.2%
£35,280,989 £37,122,841
-
Cash
+190.1%
£637,957 £1,850,947
-
Net assets
+94.4%
£21,466,911 £41,721,978
-
Employees
-11.1%
9 8
-
Operating profit
+18.1%
£21,510,062 £25,396,854
-
Profit before tax
+115.7%
£12,535,439 £27,034,773
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers